OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

CHEVRON CORP (CVX) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

CVX · CHEVRON CORP

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-10-27 · 24 filings · fetched 2026-10-27T16:10:27Z

Recent reported activity

0purchase rows on this page
9sale rows on this page
69matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-08-11Filed 2026-08-13GUSTAVSON JEFF BOfficer · President, New Energies
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reporting person does not have a pecuniary interest and disclaims beneficial ownership of these shares. These shares have been omitted from the total reported in Column 5.

F2 This number includes the acquisition of stock resulting from the reinvestment of dividends on vested restricted stock units (70) issued under the Chevron Corporation 2022 Long-Term Incentive Plan.

F3 This transaction was executed in multiple trades at prices ranging from $194.89 to $195.02. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.

F4 Option granted 1/25/2017. One-third of the shares subject to the option vested on January 31, 2018, January 31, 2019 and January 31, 2020, respectively.

F5 Option granted 1/31/2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively.

F6 The reporting person disclaims beneficial ownership of all shares underlying these securities. Such disclaimed amounts were inadvertently underreported in the reporting person's Form 3.

F7 Option granted 1/30/2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively.

References: F1, F2

M Exercise / conversionCommon Stock · Non-derivative4,850A117.24DirectForm 4 ↗0000093410-26-000171
2026-08-05Filed 2026-08-07Wirth Michael KDirector · Officer · Chairman and CEO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $186.97 to $187.05. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.

F2 This number includes the acquisition of stock resulting from the reinvestment of dividends on vested restricted stock units (589) issued under the Chevron Corporation 2022 Long-Term Incentive Plan.

F3 The reporting person owns only a 1% general partnership interest in the limited partnership. The remaining limited partnership interests are owned equally by four separate trusts for the benefit of each of the reporting person's children. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except to the extent of his pecuniary interest therein.

F4 Between March 3, 2026 and August 5, 2026, the reporting person acquired 352 shares of Chevron common stock under the Chevron Employee Savings Investment Plan, a 401(k) plan.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative5,547D186.9958DirectForm 4 ↗0000093410-26-000169
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F22

M Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative74,310D0DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F21

M Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative103,771D0DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F20

M Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative117,498D0DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F19

M Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative243,706D0DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F18

M Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative170,077D0DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F14, F15

S Sale (market/private)Common Stock · Non-derivative30,031D195.1371DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F13

S Sale (market/private)Common Stock · Non-derivative271,946D194.4805DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F12

S Sale (market/private)Common Stock · Non-derivative118,657D193.2886DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F11

S Sale (market/private)Common Stock · Non-derivative90,031D192.7486DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F10

S Sale (market/private)Common Stock · Non-derivative25,179D195.2772DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F9

S Sale (market/private)Common Stock · Non-derivative174,821D194.4221DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References:

M Exercise / conversionCommon Stock · Non-derivative74,310A138.1DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References:

M Exercise / conversionCommon Stock · Non-derivative103,771A98.71DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References:

M Exercise / conversionCommon Stock · Non-derivative117,498A73.21DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References:

M Exercise / conversionCommon Stock · Non-derivative243,706A48.51DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References:

M Exercise / conversionCommon Stock · Non-derivative170,077A55.36DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F4, F8

J Other reported codeCommon Stock · Non-derivative8,102A0DirectForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F4, F7

J Other reported codeCommon Stock · Non-derivative439,786A0IndirectBy Family TrustForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F4, F6

J Other reported codeCommon Stock · Non-derivative9,118A0IndirectBy GST TrustForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F4, F5

J Other reported codeCommon Stock · Non-derivative2,244,497D0IndirectBy Limited PartnershipForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F3, F2

S Sale (market/private)Common Stock · Non-derivative44,490D194.4974IndirectBy TrustForm 4 ↗0000093410-26-000164
2026-08-03Filed 2026-08-05HESS JOHN BDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These shares were sold in multiple transactions at prices ranging from $193.30 to $194.2999, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), and (9) through (14) to this Form 4.

F2 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F3 These shares were sold in multiple transactions at prices ranging from $194.30 to $195.01, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F4 Reflects a pro rata distribution for no consideration, from a limited partnership referred to in footnote (5). As to 457,006 shares, this transaction represents a change only in form of beneficial ownership. The remaining shares were distributed to partners as to which the reporting person has no reporting obligations.

F5 Shares are held by a limited partnership of which the reporting person is a limited partner and serves on the management committee of the general partner of the limited partnership.

F6 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F7 Shares are held by a trust established for the benefit of the reporting person and of which the reporting person is a beneficiary.

F8 This number includes the acquisition of dividend equivalent accruals on stock units (12) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.

F9 These shares were sold in multiple transactions at prices ranging from $193.87 to $194.86, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F10 These shares were sold in multiple transactions at prices ranging from $194.89 to $195.68, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F11 These shares were sold in multiple transactions at prices ranging from $191.98 to $192.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F12 These shares were sold in multiple transactions at prices ranging from $192.98 to $193.9709, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F13 These shares were sold in multiple transactions at prices ranging from $193.98 to $194.97, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F14 These shares were sold in multiple transactions at prices ranging from $194.98 to $195.69, inclusive. The price reported in Column 4 reflects the weighted average sale price.

F15 Total includes the sale of 1,303 shares directly held.

F16 Shares are held by a limited liability company of which the reporting person is a member and is a general partner and manager of a limited partnership that is the manager of the limited liability company.

F17 Shares are held by a limited liability company of which the reporting person and the reporting person's son are the sole members, and the reporting person is the manager.

F18 Option Granted: 3/6/2019. One-third of the shares subject to the option vested on March 6, 2020, March 6, 2021, and March 6, 2022, respectively, pursuant to the Hess Equity Plans.

F19 Option Granted: 3/6/2020. One-third of the shares subject to the option vested on March 6, 2021, March 6, 2022, and March 6, 2023, respectively, pursuant to the Hess Equity Plans.

F20 Option Granted: 3/6/2021. One-third of the shares subject to the option vested on March 6, 2022, March 6, 2023, and March 6, 2024, respectively, pursuant to the Hess Equity Plans.

F21 Option Granted: 3/6/2022. One-third of the shares subject to the option vested on March 6, 2023, March 6, 2024, and March 6, 2025, respectively, pursuant to the Hess Equity Plans.

F22 Option Granted: 3/6/2023. One-third of the shares subject to the option vested on March 6, 2024, March 6, 2025, and July 18, 2025, respectively, pursuant to the Hess Equity Plans.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative55,510D194.0703IndirectBy TrustForm 4 ↗0000093410-26-000164
2026-06-01Filed 2026-06-03WARNER CYNTHIA JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in common stock upon the reporting person's termination of service.

F2 1-for-1.

F3 This number includes dividend equivalent accruals (4) under the Chevron Non-Employee Directors' Equity Compensation Plan.

References: F1, F2, F3

I Other reported codePhantom Stock · Derivative20A185.83DirectForm 4 ↗0000093410-26-000152

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.